113 related articles for article (PubMed ID: 38237562)
21. Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.
Sementino E; Menges CW; Kadariya Y; Peri S; Xu J; Liu Z; Wilkes RG; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR
J Cell Physiol; 2018 Nov; 233(11):8952-8961. PubMed ID: 29904909
[TBL] [Abstract][Full Text] [Related]
22. LINC-PINT alleviates lung cancer progression via sponging miR-543 and inducing PTEN.
Wang S; Jiang W; Zhang X; Lu Z; Geng Q; Wang W; Li N; Cai X
Cancer Med; 2020 Mar; 9(6):1999-2009. PubMed ID: 31981466
[TBL] [Abstract][Full Text] [Related]
23. PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer.
Herzog A; Bian Y; Vander Broek R; Hall B; Coupar J; Cheng H; Sowers AL; Cook JD; Mitchell JB; Chen Z; Kulkarni AB; Van Waes C
Clin Cancer Res; 2013 Jul; 19(14):3808-19. PubMed ID: 23640975
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models.
Badr G; Al-Sadoon MK; Rabah DM
Free Radic Biol Med; 2013 Dec; 65():175-189. PubMed ID: 23811005
[TBL] [Abstract][Full Text] [Related]
25. [Circular RNA CircHIPK3 Promotes NCI-H1299 and NCI-H2170 Cell Proliferation through miR-379 and its Target IGF1].
Tian F; Wang Y; Xiao Z; Zhu X
Zhongguo Fei Ai Za Zhi; 2017 Jul; 20(7):459-467. PubMed ID: 28738961
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models.
Nguele Meke F; Bai Y; Ruiz-Avila D; Carlock C; Ayub J; Miao J; Hu Y; Li Q; Zhang ZY
Cancer Res Commun; 2024 Jan; 4(1):5-17. PubMed ID: 38047587
[TBL] [Abstract][Full Text] [Related]
28. Triptolide promotes degradation of the unfolded gain-of-function Tp53
Zhou J; Luo J; Li P; Zhou Y; Li P; Wang F; Mallio CA; Rossi G; Jalal AH; Filipovic N; Tian Z; Zhao X
Transl Lung Cancer Res; 2022 May; 11(5):802-816. PubMed ID: 35693277
[TBL] [Abstract][Full Text] [Related]
29. Histone Deacetylase 3 Inhibition Overcomes
Tanimoto A; Takeuchi S; Arai S; Fukuda K; Yamada T; Roca X; Ong ST; Yano S
Clin Cancer Res; 2017 Jun; 23(12):3139-3149. PubMed ID: 27986747
[No Abstract] [Full Text] [Related]
30. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
Feng H; Zhang Z; Qing X; French SW; Liu D
Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
[TBL] [Abstract][Full Text] [Related]
31. PLCE1 inhibits apoptosis of non-small cell lung cancer via promoting PTEN methylation.
Yue QY; Zhao W; Tan Y; Deng XL; Zhang YH
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6211-6216. PubMed ID: 31364122
[TBL] [Abstract][Full Text] [Related]
32. BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer.
Li Z; Zhou S; Zhang L; Su C; Hang J; Zhao Y; Su B; Zhou C
Med Oncol; 2011 Jun; 28(2):572-7. PubMed ID: 20237869
[TBL] [Abstract][Full Text] [Related]
33. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
Jin G; Kim MJ; Jeon HS; Choi JE; Kim DS; Lee EB; Cha SI; Yoon GS; Kim CH; Jung TH; Park JY
Lung Cancer; 2010 Sep; 69(3):279-83. PubMed ID: 20018398
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y
J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-19a promotes proliferative and migratory abilities of NSCLC cells by inhibiting PTEN expression.
Shi J; Han Y; Lin D; Wang K; Liu B; Gao C
J BUON; 2019; 24(3):955-962. PubMed ID: 31424647
[TBL] [Abstract][Full Text] [Related]
36. miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway.
Bu W; Luo T
DNA Cell Biol; 2017 Nov; 36(11):976-982. PubMed ID: 28872922
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
[TBL] [Abstract][Full Text] [Related]
38. LncRNA WT1-AS/miR-494-3p Regulates Cell Proliferation, Apoptosis, Migration and Invasion via PTEN/PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer.
Wu C; Yang J; Li R; Lin X; Wu J; Wu J
Onco Targets Ther; 2021; 14():891-904. PubMed ID: 33603394
[TBL] [Abstract][Full Text] [Related]
39. Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review.
Guo Y; Song J; Wang Y; Huang L; Sun L; Zhao J; Zhang S; Jing W; Ma J; Han C
Front Oncol; 2020; 10():610923. PubMed ID: 33363040
[TBL] [Abstract][Full Text] [Related]
40. The apoptotic effect of simvastatin via the upregulation of BIM in nonsmall cell lung cancer cells.
Lee HY; Kim IK; Lee HI; Mo JY; Yeo CD; Kang HH; Moon HS; Lee SH
Exp Lung Res; 2016; 42(1):14-23. PubMed ID: 26756263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
